Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 1
1984 2
1985 1
1986 1
1987 1
1988 1
1989 1
1990 1
1991 1
1992 2
1993 5
1994 3
1995 3
1997 5
1998 3
1999 9
2000 17
2001 13
2002 11
2003 20
2004 26
2005 24
2006 34
2007 32
2008 30
2009 35
2010 66
2011 63
2012 69
2013 69
2014 61
2015 83
2016 89
2017 94
2018 108
2019 111
2020 179
2021 252
2022 317
2023 241
2024 212
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,026 results

Results by year

Filters applied: . Clear all
Page 1
Cannabis and synaptic reprogramming of the developing brain.
Bara A, Ferland JN, Rompala G, Szutorisz H, Hurd YL. Bara A, et al. Nat Rev Neurosci. 2021 Jul;22(7):423-438. doi: 10.1038/s41583-021-00465-5. Epub 2021 May 21. Nat Rev Neurosci. 2021. PMID: 34021274 Free PMC article. Review.
Premenstrual disorders.
Yonkers KA, Simoni MK. Yonkers KA, et al. Am J Obstet Gynecol. 2018 Jan;218(1):68-74. doi: 10.1016/j.ajog.2017.05.045. Epub 2017 May 29. Am J Obstet Gynecol. 2018. PMID: 28571724 Review.
Yasmin: the reason why.
Thorneycroft IH. Thorneycroft IH. Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:13-8; discussion 42-3. Eur J Contracept Reprod Health Care. 2002. PMID: 12659402 Review.
The new drospirenone-containing oral contraceptive (Yasmin, Schering AG, Berlin, Germany) offers the traditional non-contraceptive benefits; however, due to its unique antimineralocorticoid and antiandrogenic properties, new and unique benefits have been observed. ...
The new drospirenone-containing oral contraceptive (Yasmin, Schering AG, Berlin, Germany) offers the traditional non-contraceptive be …
Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial.
El Taha L, Abu Musa A, Khalifeh D, Khalil A, Abbasi S, Nassif J. El Taha L, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:205-212. doi: 10.1016/j.ejogrb.2021.10.029. Epub 2021 Oct 30. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34826668 Clinical Trial.
OBJECTIVE: To compare the efficacy of dienogest with the combined oral contraceptive pill (COC) Yasmin for the control of endometriosis-associated pelvic pain. STUDY DESIGN: Seventy women with endometriosis-associated chronic pelvic pain, dysmenorrhoea or both for >6 mo …
OBJECTIVE: To compare the efficacy of dienogest with the combined oral contraceptive pill (COC) Yasmin for the control of endometrios …
Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
Mansour D. Mansour D. Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:35-41; discussion 42-3. Eur J Contracept Reprod Health Care. 2002. PMID: 12659405 Review.
It contains 3 mg drospirenone, a progestogen resembling endogenous progesterone, and 30 microg ethinylestradiol (DRSP/EE, Yasmin, Schering AG, Berlin, Germany). It has been shown to be highly effective in preventing pregnancies as well as providing good cycle control. ...
It contains 3 mg drospirenone, a progestogen resembling endogenous progesterone, and 30 microg ethinylestradiol (DRSP/EE, Yasmin, Sch …
A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Li J, Ren J, Sun W. Li J, et al. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:13-21. doi: 10.1016/j.ejogrb.2016.11.013. Epub 2016 Nov 16. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 27923166 Review.
OBJECTIVES: To systematically review the impact of Yasmin (drospirenone pill) compares with other standard treatments for symptoms of Polycystic Ovary Syndrome (PCOS). ...
OBJECTIVES: To systematically review the impact of Yasmin (drospirenone pill) compares with other standard treatments for symptoms of …
The Efficacy of the Yasmin[Ethinylestradiol-Drospirenone (0.03/3 mg)] Treatment for Postoperative Abortion: A Protocol of Meta-Analysis.
Tian T, Feng H, Liao X, Su Q, Li Y, Li X. Tian T, et al. Front Med (Lausanne). 2022 Apr 15;9:746668. doi: 10.3389/fmed.2022.746668. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492367 Free PMC article.
To improve symptoms and reduce these complications, antibiotics, motherwort, and Yasmin[Ethinylestradiol-Drospirenone (0.03/3 mg)] are clinically used alone or in combination after induced abortion. ...CONCLUSION: The results will provide reliable data basis for the value …
To improve symptoms and reduce these complications, antibiotics, motherwort, and Yasmin[Ethinylestradiol-Drospirenone (0.03/3 mg)] ar …
Safety assessment of Yasmin: Real-world adverse event analysis using the FAERS database.
Xu W, Zhu L, Wang J, Shi L, Tang X, Chen Q, Wang L. Xu W, et al. Eur J Obstet Gynecol Reprod Biol. 2024 Oct;301:12-18. doi: 10.1016/j.ejogrb.2024.07.048. Epub 2024 Jul 26. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 39084181 Free article.
BACKGROUND: This study aimed to elucidate the scope and nature of adverse events (AEs) associated with Yasmin. METHODS: Among the 17,035,572 AE reports collected from the Food and Drug Administration Adverse Event Reporting System (FAERS) database between January 2004 and …
BACKGROUND: This study aimed to elucidate the scope and nature of adverse events (AEs) associated with Yasmin. METHODS: Among the 17, …
2,026 results